SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Idenix Pharmaceuticals (IDIX)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: DewDiligence_on_SI8/16/2010 12:37:55 AM
   of 412
 
IDIX ‘ReadMeFirst’ updated:

2Q10 financial results;
liquidity and cash usage;
transcript from 2Q10 CC
latest investor slide set;
2010-2011 news flow;
composition of BoD (updated for departure of Steven Projan)
table of insider shareholdings and options;
table of major shareholders;
musings on buyout vig;
why investors tend to overlook IDX899;
phase-2b data for GSK’s ‘572 integrase inhibitor;
new version of “The New Battle Lines in HIV”;
new version of “HCV: Most Likely to Succeed”;
new version of “Who’s Who in All-Oral HCV Programs.”

siliconinvestor.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News